ICSR Submission Support
ICSR Submission Support
Reliable pharmacovigilance reporting safety submissions for FDA and EMA.
Accurate and timely Individual Case Safety Report (ICSR) submissions are critical for maintaining regulatory compliance and protecting patient safety. At Aquila Solutions, we support pharmaceutical and biotechnology companies with the preparation, validation, and submission of ICSR reports in E2B(R3) format for both US FDA FAERS and EMA EudraVigilance systems.
Our experienced regulatory publishing team ensures that your safety reports meet evolving pharmacovigilance standards while maintaining efficient submission timelines. With a responsive team and streamlined workflows, we help clients maintain compliance while keeping reporting operations running smoothly.
Contact us today to learn how Aquila Solutions can support your ICSR submission requirements and help your organization stay compliant with global safety reporting obligations.
Understanding Individual Case Safety Reporting
Individual Case Safety Reports (ICSRs) are standardized reports used by the pharmaceutical industry to document and submit adverse event and safety information associated with medicinal products. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require these reports to be submitted electronically in E2B(R3) format, with the FDA requirement taking effect on April 1, 2026, to support consistent data exchange between sponsors and regulatory systems.
ICSR reporting plays a vital role in pharmacovigilance programs by ensuring that regulators can continuously monitor the safety profile of approved and investigational products. Properly structured safety reports help authorities evaluate potential risks, identify safety signals, and protect public health.
Because these submissions involve complex data structures, strict validation rules, and evolving regulatory requirements, many organizations rely on experienced regulatory partners to ensure accuracy and compliance.
Why Accurate Safety Reporting Matters
Timely and accurate ICSR reporting is a core requirement for maintaining compliance with global pharmacovigilance regulations. Health authorities rely on these submissions to monitor drug safety and assess potential risks associated with medicinal products. Failure to submit properly formatted reports or missing reporting timelines can result in regulatory scrutiny, compliance issues, and delays in regulatory review processes.
At Aquila Solutions, we understand the challenges that pharmacovigilance teams face when managing safety reporting requirements across multiple regulatory systems. Our team supports sponsors by ensuring that ICSR data is properly structured, validated, and prepared for submission in accordance with current E2B(R3) standards.
By partnering with Aquila Solutions, organizations gain access to experienced regulatory publishing specialists who can help manage submission workflows, maintain compliance, and support pharmacovigilance teams during periods of high reporting activity.
How Aquila Supports ICSR Reporting
At Aquila Solutions, we provide specialized support for organizations managing pharmacovigilance safety reporting requirements. Our team works closely with clients to ensure that ICSR submissions meet regulatory standards while maintaining efficient turnaround times and submission accuracy.
ICSR Preparation
- E2B(R3) XML creation and structuring
- Safety data formatting and validation
- Compliance checks against regulatory reporting standards
Regulatory Submission Management
- FAERS electronic submission support (US FDA)
- EudraVigilance reporting support (EMA)
- Electronic gateway submission assistance
- Submission tracking and confirmation monitoring
Data Validation and Quality Review
- Pre-submission validation checks
- XML schema compliance verification
- Quality control review to ensure submission readiness
Regulatory Guidance and Support
- E2B(R3) transition assistance
- Safety reporting workflow guidance
- Ongoing regulatory updates and best practice support
Our experienced team is committed to providing responsive support and efficient submission management, helping clients maintain compliance with regulatory safety reporting requirements.
Aquila’s Approach to Reliable Safety Submissions
At Aquila Solutions, we bring extensive regulatory publishing expertise and a deep understanding of electronic safety reporting standards. Our team works closely with clients to ensure ICSR submissions are accurate, compliant, and delivered on time.
Regulatory Safety Expertise
Our specialists have extensive experience supporting pharmacovigilance reporting and electronic safety submissions across multiple regulatory systems.
Secure Data Handling
We apply strict data protection practices to safeguard sensitive pharmacovigilance and patient safety information.
Up-to-Date Regulatory Alignment
We continuously monitor evolving pharmacovigilance regulations to ensure submissions remain aligned with current reporting requirements.
Partner With Aquila for Reliable ICSR Reporting
Managing pharmacovigilance reporting requirements can be complex and time-sensitive. Aquila Solutions helps simplify the process by providing reliable support for E2B(R3) ICSR preparation, validation, and submission management.
Our experienced regulatory publishing team works closely with pharmaceutical and biotechnology organizations to ensure that safety reports are submitted accurately and on time. With efficient workflows, strong regulatory expertise, and a commitment to responsiveness, we help clients maintain compliance while supporting their broader pharmacovigilance operations.
As global regulatory systems continue to evolve, Aquila Solutions remains prepared to support emerging reporting standards across multiple health authorities.
Take the first step toward ensuring compliance and efficient safety reporting by partnering with Aquila Solutions.